The Justice Department reclassified marijuana as a Schedule III drug, a shift that affects research and taxes but not legalization ...

Anti-rescheduling provision advances in Congress; Lawmaker: “a lot” of colleagues smoke marijuana; LA medical cannabis in ...

The FDA moved approved marijuana products to schedule III to expand therapy access and state medical programs while maintaining federal controls.

On April 22, 2026, Acting Attorney General Todd Blanche issued a final order immediately placing both FDA-approved marijuana products ...

The Justice Department and Drug Enforcement Administration have reclassified marijuana to recognize its medical value, a historic shift that also complicates regulation for states like Maryland with ...

The Department of Transportation officially clarifies its rules on Schedule III cannabis. If you hold a safety-sensitive role ...

On April 22, 2026, the Acting U.S. Attorney General ordered two categories of marijuana moved from Schedule I to Schedule III of the Controlled Substances Act (CSA): FDA-approved drug products ...

Federal drug policy is undergoing a major shift. It could affect Mississippi medical marijuana. President Donald Trump recently signed an executive order changing the classification for medical ...

A cannabis industry group calls President Trump's reclassification of state-licensed medical marijuana as a less-dangerous drug "the most significant federal advancement in cannabis policy" in decades ...

If board members object to a federal change, they must publicly issue their reasons and allow for a hearing process before ...